We are improving our search experience. To check which content you have full access to, or for advanced search, go back to the old search.

Search

Please fill in this field.

Search Results

Showing 81-100 of 10,000 results
  1. Secondary IDH1 resistance mutations and oncogenic IDH2 mutations cause acquired resistance to ivosidenib in cholangiocarcinoma

    The mutant IDH1 inhibitor ivosidenib improves outcomes for patients with IDH1- mutated cholangiocarcinoma, but resistance inevitably develops....

    James M. Cleary, Betty Rouaisnel, ... Julie-Aurore Losman in npj Precision Oncology
    Article Open access 02 September 2022
  2. Brentuximab vedotin resistance in classic Hodgkin's lymphoma and its therapeutic strategies: a review

    Background

    Bone marrow cancer has been at the forefront of cancer research. The propensity of cancers to extravasate to the bone makes it a very...

    Dayeeta Bera, Dattatreya Roy in Future Journal of Pharmaceutical Sciences
    Article Open access 09 February 2024
  3. Causal relationship between insulin resistance and sarcopenia

    Sarcopenia is a multifactorial disease characterized by reduced muscle mass and function, leading to disability, death, and other diseases. Recently,...

    Zi-jian Liu, Cui-feng Zhu in Diabetology & Metabolic Syndrome
    Article Open access 15 March 2023
  4. Insulin resistance is a cardiovascular risk factor in hypertensive adults without type 2 diabetes mellitus

    Background

    Metabolic syndrome refers to the association among several cardiovascular risk factors: obesity, dyslipidemia, hyperglycemia, and...

    Rafael Garcia-Carretero, Oscar Vazquez-Gomez, ... Angel Gil-de-Miguel in Wiener klinische Wochenschrift
    Article 09 October 2023
  5. Application of impulse oscillometry to detect interstitial lung disease and airway disease in adults with rheumatoid arthritis

    Background

    We conducted a retrospective observational study to explore the potential application of impulse oscillometry (IOS) as an alternative to...

    Wen-Chien Cheng, Shih-Hsin Chang, ... Der-Yuan Chen in BMC Pulmonary Medicine
    Article Open access 08 September 2023
  6. Insulin resistance in adipose tissue and metabolic diseases

    Adipose tissue regulates systemic energy metabolism through adipokine production as well as energy storage and energy supply to other organs in...

    Yukiko Imi, Wataru Ogawa, Tetsuya Hosooka in Diabetology International
    Article 22 December 2022
  7. Gut microbiota in insulin resistance: a bibliometric analysis

    Background

    Insulin resistance (IR) is considered the pathogenic driver of diabetes, and can lead to obesity, hypertension, coronary artery disease,...

    Weiwei Tian, Li Liu, ... Junning Zhao in Journal of Diabetes & Metabolic Disorders
    Article 14 February 2024
  8. Overcoming resistance to programmed cell death protein 1 (PD-1) blockade with allogeneic invariant natural killer T-cells (iNKT)

    Gastric cancer is the 5 th most common malignancy worldwide with only 36% of patients with metastatic disease surviving beyond 5 years. Despite...

    Matthew J. Hadfield, Howard Safran, ... Benedito A. Carneiro in Oncogene
    Article 29 January 2024
  9. Antimicrobial Resistance in Urinary Tract Infections

    Purpose of Review

    This review aims to summarize the recent literature regarding antimicrobial-resistant urinary tract infections in the United States...

    Tiffany L. Damm, Anne P. Cameron in Current Bladder Dysfunction Reports
    Article 21 February 2023
  10. The association between hyperuricemia and insulin resistance surrogates, dietary- and lifestyle insulin resistance indices in an Iranian population: MASHAD cohort study

    Background

    Previous studies have reported insulin resistance (IR) to be associated with hyperuricemia. In this study, we aimed to assess the possible...

    Najmeh Seifi, Mina Nosrati, ... Majid Ghayour-Mobarhan in Nutrition Journal
    Article Open access 04 January 2024
  11. A multiparameter liquid biopsy approach allows to track melanoma dynamics and identify early treatment resistance

    Melanoma heterogeneity is a hurdle in metastatic disease management. Although the advent of targeted therapy has significantly improved patient...

    Maria Chiara Scaini, Cristina Catoni, ... Antonio Rosato in npj Precision Oncology
    Article Open access 28 March 2024
  12. Exceptional response to lorlatinib and cabozantinib in ROS1-rearranged NSCLC with acquired F2004V and L2086F resistance

    Patients with ROS1-rearranged NSCLC demonstrate excellent disease control with ROS1-targeted therapy, but acquired resistance is inevitable. Of...

    Mandy Sakamoto, Tejas Patil in npj Precision Oncology
    Article Open access 08 June 2023
  13. Optimum Dose of Resistance Exercise for Cardiovascular Health and Longevity: Is More Better?

    Purpose of Review

    Although there is extensive research on how much aerobic exercise to prescribe in order to reduce the risks of cardiovascular...

    Duck-chul Lee, I-Min Lee in Current Cardiology Reports
    Article 14 October 2023
  14. Thyroid cancer and insulin resistance

    Thyroid cancer has shown a parallel increase with diabetes in the last few years. This narrative review aims to explain the association between these...

    Gabriela Brenta, Fernando Di Fermo in Reviews in Endocrine and Metabolic Disorders
    Article 14 November 2023
  15. Rewiring of the N-Glycome with prostate cancer progression and therapy resistance

    An understanding of the molecular features associated with prostate cancer progression (PCa) and resistance to hormonal therapy is crucial for the...

    William Butler, Colin McDowell, ... Jiaoti Huang in npj Precision Oncology
    Article Open access 24 February 2023
  16. Nanovaccines to combat drug resistance: the next-generation immunisation

    Background

    The present review envisages the role of nanovaccines to combat the global challenges of antimicrobial resistance. Nanovaccines are a novel...

    K. Manju, S. Niranjan Raj, ... Syed Baker in Future Journal of Pharmaceutical Sciences
    Article Open access 31 July 2023
  17. Efficacy of rechallenge immunotherapy after immune monotherapy resistance in patients with advanced non-small cell lung cancer

    Purpose

    Drug resistance inevitably occurs despite the encouraging results of immunotherapy. This study attempted to investigate immunotherapy...

    Manyi Xu, Yue Hao, ... Zhengbo Song in Journal of Cancer Research and Clinical Oncology
    Article 17 November 2023
  18. Clonal haematopoiesis, ageing and kidney disease

    Clonal haematopoiesis of indeterminate potential (CHIP) is a preclinical condition wherein a sizeable proportion of an individual’s circulating blood...

    Caitlyn Vlasschaert, Matthew B. Lanktree, ... Pradeep Natarajan in Nature Reviews Nephrology
    Article 26 October 2023
  19. Molecular mechanism of MLCK1 inducing 5-Fu resistance in colorectal cancer cells through activation of TNFR2/NF-κB pathway

    Background and aims

    Chemotherapy resistance in colorectal cancer have been faced with significant challenges in recent years. Particular interest is...

    Huifen Tang, Hui Zhou, ... Ning Li in Discover Oncology
    Article Open access 12 May 2024
  20. Posttranslational splicing modifications as a key mechanism in cytarabine resistance in acute myeloid leukemia

    Despite the approval of several drugs for AML, cytarabine is still widely used as a therapeutic approach. However, 85% of patients show resistance...

    María Luz Morales, Roberto García-Vicente, ... María Linares in Leukemia
    Article Open access 08 July 2023
Did you find what you were looking for? Share feedback.